Escalade (ESCA) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
4 Nov, 2025Executive summary
Leadership transition with Patrick Griffin appointed Interim President and CEO, emphasizing continuity in strategy and operations.
Net sales for Q3 2025 were $67.8 million, nearly flat year-over-year, with growth in archery, table tennis, billiards, and safety offset by declines in basketball and strategic category exits.
Gross margin improved to 28.1% from 24.8% year-over-year, driven by operational efficiency, lower fixed costs, and facility consolidation, despite tariff-related costs.
Net income for Q3 2025 was $5.6 million ($0.40 per diluted share), nearly unchanged from $5.7 million ($0.40 per share) last year.
Strategic focus remains on product innovation, brand development, and long-term value creation.
Financial highlights
Q3 2025 net sales: $67.8 million (up 0.1% year-over-year); nine months: $177.6 million (down 5.3%).
Gross margin for Q3 2025: 28.1% (up 334 basis points year-over-year); nine months: 26.6% (up 190 bps).
Q3 2025 net income: $5.6 million; diluted EPS: $0.40; EBITDA: $8.6 million, down from $9.9 million due to prior-year asset sale gain.
Cash and equivalents at period end: $3.5 million; total debt: $20.2 million, down 31.4% year-over-year.
Net leverage at 0.7x as of September 30, 2025.
Outlook and guidance
Management expects cautious consumer spending and softer holiday sales in Q4, with strong demand for premium products but softness in lower-priced segments.
Expects tariff-related cost impact to be lower in Q4 compared to Q3.
Improved gross margin performance is expected to be sustained, supported by cost discipline and a reduced operational footprint.
Management expects sufficient cash flow and credit access to meet operational and growth needs for the remainder of 2025.
Results for the period are not necessarily indicative of full-year 2025 due to ongoing market uncertainties.
Latest events from Escalade
- Gross margin and net income rose despite lower sales, with net leverage reduced to 0.3x EBITDA.ESCA
Q4 202527 Feb 2026 - Q2 sales fell 7.7%, but strong cash flow enabled debt reduction and margin focus.ESCA
Q2 20242 Feb 2026 - Q3 net income rose 33% to $5.7M on margin gains and debt reduction despite a 7.7% sales drop.ESCA
Q3 202418 Jan 2026 - Margins and cash flow improved despite lower sales, driven by cost cuts and inventory reduction.ESCA
Q4 202416 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and say-on-pay frequency.ESCA
Proxy Filing2 Dec 2025 - Net income up 47% on higher margins despite 3.2% sales drop; debt and costs down.ESCA
Q1 202524 Nov 2025 - Sales fell 13.1% year-over-year, but gross margin and balance sheet strength improved.ESCA
Q2 202516 Nov 2025